Career history of Daniela Oniciu
Former positions of Daniela Oniciu
| Companies | Position | Start | End |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Chief Tech/Sci/R&D Officer | - | 30/12/2023 |
| NEUROBO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/05/2014 | 31/10/2018 |
| ABIONYX PHARMA | Corporate Officer/Principal | 23/02/2010 | 31/01/2014 |
| PFIZER, INC. | Corporate Officer/Principal | 30/11/2004 | 31/01/2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 31/01/2001 | 31/12/2003 |
| Creative Pharma Advisors LLC | Founder | - | - |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Chief Operating Officer | - | - |
Training of Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Statistics
International
| United States | 7 |
| France | 2 |
| Romania | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Stock Market
- Insiders
- Daniela Oniciu
- Experience
